Consistent with our data, the GMP gene signature was significantly positively enriched in NPM1-deficient human leukemic cells compared to control shREN cells, and the GMP-like gene signature was significantly negatively enriched, suggesting that NPM1 might be a driver of leukemia (Fig 4J). The gene discussed is NT5C2; the disease is leukemia.